Browse our anti-APOC3 (APOC3) Antibodies

Full name:
anti-Apolipoprotein C-III Antibodies (APOC3)
On are 138 Apolipoprotein C-III (APOC3) Antibodies from 16 different suppliers available. Additionally we are shipping APOC3 Kits (61) and APOC3 Proteins (43) and many more products for this protein. A total of 246 APOC3 products are currently listed.
list all antibodies Gene Name GeneID UniProt
APOC3 345 P02656
APOC3 11814 P33622
APOC3 24207  

Show all species

Show all synonyms

Most Popular Reactivities for anti-APOC3 (APOC3) Antibodies

Select your species and application

anti-Human APOC3 Antibodies:

anti-Mouse (Murine) APOC3 Antibodies:

anti-Rat (Rattus) APOC3 Antibodies:

All available anti-APOC3 Antibodies

Go to our pre-filtered search.

Top referenced anti-APOC3 Antibodies

  1. Human Polyclonal APOC3 Primary Antibody for IHC (p), IP - ABIN153496 : Wang, Song, Wagner, Pachuk, Subramanian: Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum. in Journal of lipid research 2011 (PubMed)

More Antibodies against APOC3 Interaction Partners

Human Apolipoprotein C-III (APOC3) interaction partners

  1. Plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9 (show PCSK9 Antibodies)), apolipoprotein C-III (apoC3) and small dense low density lipoprotein cholesterol (sdLDL-C) showed significant interactions with current dyslipidemias, and were predictive in the screening.

  2. Novel sequencing techniques are detecting rare variants with larger effect sizes (eg, APOC3) , which may further improve on Cardiovascular disease risk prediction.

  3. The APOC3 rs2070666 A allele is a risk factor for NAFLD independent of obesity, dyslipidemia, and PNPLA3 rs738409, and it might contribute to increased liver fat content in Chinese Han population.

  4. ApoC-III levels are significantly associated with incident coronary artery disease risk. Elevated levels of remnant lipoproteins, small dense low-density lipoprotein, and low-grade inflammation may explain this association.

  5. The authors findings confirm an association of APOC3 with gout.

  6. Accumulating evidence indicates that apolipoprotein C-III is a multifaceted protein which not only regulates triglyceride metabolism, but also participates in the atherosclerotic lesion formation and several other pathological processes involved in atherosclerosis.

  7. Our results showed that APOC3 was closely associated with the inflammatory process in ECs, and that this process was characterized by the increased expression of TNF-alpha (show TNF Antibodies). Inflammatory processes further disrupted the tight junctions (TJs) between HUVECs by causing increased expression of JAM-1 (show F11R Antibodies).

  8. Transgenic mice expressing human APOC3in the C57BL/6J background have been described. The study found that hypertriglyceridemia per se is not an independent risk factor for beta cell dysfunction in ApoC3 transgenic mice.

  9. ApoA-1 (show APOA1 Antibodies) and ApoC-III may be used as differentiating and predictive markers for SCLC [ small cell lung cancer ].

  10. The results of our meta-analysis point to a strong link between both APOA5 (show APOA5 Antibodies) -1131T>C and APOC3 -455T>C polymorphisms and an increased risk of coronary heart disease .

Mouse (Murine) Apolipoprotein C-III (APOC3) interaction partners

  1. These data strongly suggest that intestinal apoC-III is not a FoxO1 (show FOXO1 Antibodies) target and support the idea that apoC-III is not regulated coordinately with hepatic apoC-III, and establishes another key aspect of apoC-III that is unique in the intestine from the liver.

  2. APOC3, whose dysregulation is liable for hypertriglyceridemia, is not a predisposing factor for linking overnutrition to NAFLD (show TSC2 Antibodies) in obesity

  3. Severe hypertriglyceridaemia resulting from ApoCIII overexpression promotes restenosis and atherosclerosis

  4. Under conditions of islet insulin (show INS Antibodies) resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of beta-cell function.

  5. decreased ApoAI synthesis might be accounted for the lower plasma HDL (show HSD11B1 Antibodies) level in ApoCIII transgenic mice

  6. ApoCIII hyperactivates beta cell CaV1 (show CAV1 Antibodies) channels through SR-BI (show SCARB1 Antibodies)/beta1 integrin-dependent coactivation of PKA and Src (show SRC Antibodies).

  7. Increased plasma APOC3 concentrations predispose mice to diet-induced nonalcoholic fatty liver and hepatic insulin (show INS Antibodies) resistance.

  8. Glucose induces apoCIII transcription, which may represent a mechanism linking hyperglycemia, hypertriglyceridemia, and cardiovascular disease in type 2 diabetes.

  9. PGC-1beta (show PPARGC1B Antibodies) regulates plasma triglyceride metabolism through stimulating apolipoprotein C3 (APOC3) expression and elevating APOC3 levels in circulation

  10. The apoC-III metabolism may contribute to dyslipidemia in CKD, and this requires further investigation.

Pig (Porcine) Apolipoprotein C-III (APOC3) interaction partners

  1. gene polymorphisms in APOA5 (show APOA5 Antibodies) and APOC3 are associated with meat quality traits in Kele pigs

  2. changes in apolipoprotein A-I (show APOA1 Antibodies) and apo (show C9orf3 Antibodies) C-III mRNA were reflected in their corresponding plasma levels

Cow (Bovine) Apolipoprotein C-III (APOC3) interaction partners

  1. apoC-I (show APOC1 Antibodies) and apoC-III inhibit lipolysis by displacing LPL (show LPL Antibodies) from lipid emulsion particles. We also propose a role for these apolipoproteins in the irreversible inactivation of LPL (show LPL Antibodies) by factors such as angptl4 (show ANGPTL4 Antibodies).

APOC3 Antigen Profile

Antigen Summary

Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase\; it is thought to delay catabolism of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia.

Alternative names and synonyms associated with APOC3

  • apolipoprotein C-III (APOC3) antibody
  • apolipoprotein C-III (Apoc3) antibody
  • Apo-CIII antibody
  • Apoc antibody
  • ApoC-III antibody
  • APOC3 antibody
  • APOCIII antibody
  • HALP2 antibody

Protein level used designations for APOC3

apolipoprotein C-III , apo-CIII , apoC-III , apolipoprotein C3 , apolipoprotein C-3 , apolipoprotein CIII

451563 Pan troglodytes
696726 Macaca mulatta
345 Homo sapiens
11814 Mus musculus
24207 Rattus norvegicus
100135481 Cavia porcellus
406187 Sus scrofa
408009 Bos taurus
442970 Canis lupus familiaris
Selected quality suppliers for anti-APOC3 (APOC3) Antibodies
Did you look for something else?